ERG overexpression in prostate cancers promotes the development of widespread changes in gene expression and chromatin landscapes, leading to redistribution of key transcription factors in prostate cancers positive for the TMPRSS2-ERG fusion gene. The overexpression of ERG is further assisted by the development of a super-enhancer in the ERG locus.
References
Li, J. et al. Science 275, 1943–1947 (1997).
Taylor, B.S. et al. Cancer Cell 18, 11–22 (2010).
Berger, M.F. et al. Nature 470, 214–220 (2011).
Tomlins, S.A. et al. Science 310, 644–648 (2005).
Cancer Genome Atlas Research Network. Cell 163, 1011–1025 (2015).
Tomlins, S.A. et al. Neoplasia 10, 177–188 (2008).
Adamo, P. & Ladomery, M.R. Oncogene 35, 403–414 (2016).
Kron, K.J. et al. Nat. Genet., 49 1336–1345 (2017)10.1038/ng.3930.
Whyte, W.A. et al. Cell 153, 307–319 (2013).
Cao, F. et al. Sci. Rep. 7, 2186 (2017).
Pott, S. & Lieb, J.D. Nat. Genet. 47, 8–12 (2015).
Wang, Q. et al. Mol. Cell 27, 380–392 (2007).
Babu, D. & Fullwood, M.J. Nucleus 6, 382–393 (2015).
Wang, Q., Carroll, J.S. & Brown, M. Mol. Cell 19, 631–642 (2005).
Rickman, D.S. et al. Proc. Natl. Acad. Sci. USA 109, 9083–9088 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.J.F. declares two patents on chromatin interaction technologies.
Rights and permissions
About this article
Cite this article
Babu, D., Fullwood, M. Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer. Nat Genet 49, 1294–1295 (2017). https://doi.org/10.1038/ng.3944
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.3944
- Springer Nature America, Inc.
This article is cited by
-
TP63–TRIM29 axis regulates enhancer methylation and chromosomal instability in prostate cancer
Epigenetics & Chromatin (2024)
-
Super-enhancers complexes zoom in transcription in cancer
Journal of Experimental & Clinical Cancer Research (2023)
-
Super-enhancer function and its application in cancer targeted therapy
npj Precision Oncology (2020)
-
Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms
Experimental & Molecular Medicine (2020)